BNP Paribas Discount Zert MRNA 26.../ DE000PC4JQX9 /
7/9/2024 9:40:23 PM | Chg.+0.090 | Bid9:47:42 PM | Ask9:47:42 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
63.690EUR | +0.14% | 63.680 Bid Size: 3,100 |
63.730 Ask Size: 3,100 |
Moderna Inc | - USD | 9/26/2024 | Call |
GlobeNewswire
6/13
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
6/5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
5/22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
5/12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
5/8
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
5/2
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/1
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
5/1
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...